Meta-Analysis Open Access
Copyright ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Transplant. Dec 24, 2016; 6(4): 790-797
Published online Dec 24, 2016. doi: 10.5500/wjt.v6.i4.790
Incidence of kidney stones in kidney transplant recipients: A systematic review and meta-analysis
Wisit Cheungpasitporn, Charat Thongprayoon, Michael A Mao, Wonngarm Kittanamongkolchai, Insara J Jaffer Sathick, Tsering Dhondup, Stephen B Erickson, Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN 55905, United States
Author contributions: Cheungpasitporn W and Thongprayoon C contributed equally to this work; Cheungpasitporn W and Thongprayoon C: Performed the search, analysis and interpretation of data, analysis of data and final approval of the version to be published; Mao MA, Kittanamongkolchai W, Jaffer Sathick IJ and Dhondup T: Critical revising of the intellectual content and final approval of the version to be published; Erickson SB: Concept and design, critical revising of the intellectual content and final approval of the version to be published.
Conflict-of-interest statement: All authors report no conflicts-of-interest.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Wisit Cheungpasitporn, MD, Assistant Professor, Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States. wcheungpasitporn@gmail.com
Telephone: +1-507-2667093 Fax: +1-507-2667891
Received: May 18, 2016
Peer-review started: May 18, 2016
First decision: July 27, 2016
Revised: September 8, 2016
Accepted: October 22, 2016
Article in press: October 24, 2016
Published online: December 24, 2016
Processing time: 210 Days and 8.7 Hours

Abstract
AIM

To evaluate the incidence and characteristics of kidney stones in kidney transplant recipients.

METHODS

A literature search was performed using MEDLINE, EMBASE, and Cochrane Database of Systematic Reviews from the inception of the databases through March 2016. Studies assessing the incidence of kidney stones in kidney transplant recipients were included. We applied a random-effects model to estimate the incidence of kidney stones.

RESULTS

Twenty one studies with 64416 kidney transplant patients were included in the analyses to assess the incidence of kidney stones after kidney transplantation. The estimated incidence of kidney stones was 1.0% (95%CI: 0.6%-1.4%). The mean duration to diagnosis of kidney stones after kidney transplantation was 28 ± 22 mo. The mean age of patients with kidney stones was 42 ± 7 years. Within reported studies, approximately 50% of kidney transplant recipients with kidney stones were males. 67% of kidney stones were calcium-based stones (30% mixed CaOx/CaP, 27%CaOx and 10%CaP), followed by struvite stones (20%) and uric acid stones (13%).

CONCLUSION

The estimated incidence of kidney stones in patients after kidney transplantation is 1.0%. Although calcium based stones are the most common kidney stones after transplantation, struvite stones (also known as “infection stones”) are not uncommon in kidney transplant recipients. These findings may impact the prevention and clinical management of kidney stones after kidney transplantation.

Key Words: Nephrolithiasis; Incidence; Kidney stones; Kidney transplantation; Transplantation

Core tip: The authors performed this meta-analysis to assess the incidence and characteristics of kidney stones in kidney transplant recipients. The estimated incidence of kidney stones in patients after kidney transplantation is 1.0%. Calcium based stones (CaOx and CaP) are the most common kidney stones after transplantation following by struvite stones and uric acid stones. The findings from this study may impact the management of kidney stone prevention after kidney transplantation.
INTRODUCTION

Kidney stones are one of the most common metabolic disorders and urological problems with a prevalence of 7.2%-7.7% in the adult population, and a ten-year recurrence rate of ≥ 30%[1-4]. The incidence of kidney stones is increasing especially in industrialized countries with an estimated global prevalence between 10%-15%[5-8]. Approximately 13% of men and 7% women will have a kidney stone during their lifetime[5,8].

Previous studies have shown that stone recurrence rates may be lower, when glomerular filtration rate (GFR) reduced[9,10]. Thus, patients with advanced chronic kidney disease (CKD) or end-stage kidney disease (ESRD) may encounter less stone disease[10], reported being as low as 0.68%[11]. After successful kidney transplantation, ESRD patients subsequently have significant improvement in renal function resulting in urinary excretion of metabolites that increases risk of stone disease. Studies have identified kidney stones in allograft kidney as one of the serious problems in kidney transplant recipients[12-40]. However, unlike the general population, the incidence and characteristics of kidney stones in kidney transplant recipients are not well studied. The aim of this meta-analysis was to appraise the incidence and types of kidney stones after kidney transplantation.

MATERIALS AND METHODS

Cheungpasitporn W and Thongprayoon C individually examined published studies and conference abstracts indexed in MEDLINE, EMBASE, and Cochrane Database from the inception of the databases through March 2016. The search strategy used is detailed in the supplementary material (Item 1). Further pertinent studies were retrieved by conducting a manual search using references from the articles that were reclaimed from the search strategy noted above. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines for systematic reviews and meta-analyses[41] and previously published guidelines[42,43].

The inclusion criteria were as follows: (1) randomized controlled trials or observational studies (case-control, cross-sectional, cohort studies, or case series); (2) patient population age > 18 years old; and (3) data on kidney stones in kidney transplant recipients were provided. The search was limited to English-language studies. Both published studies and conference abstracts were incorporated. Study eligibility was independently determined by the two investigators mentioned earlier. Differing decisions were settled by joint agreement.

A standardized information collection form was applied to derive the following data: The first author of each study, study design, year of publication, country where the study was conducted, number of kidney transplant recipients studied, number of patients with kidney stone, age and gender of patients with kidney stones, time of diagnosis after kidney transplantation, type of donor (Live or deceased donor), type and location of kidney stones, and period of follow-up.

Statistical analysis

MetaXL software (EpiGear International Pty Ltd)[44] was utilized for data analysis. The incidence rates (IRs) and 95%CIs of adverse effects were reported using a DerSimonian-Laird random-effects model[45]. A random-effects model was implemented due to the high likelihood of inter-study variances. The Cochran Q test was completed to assess statistical heterogeneity. The I2 statistic was added to evaluate the degree of variation across studies related to heterogeneity instead of chance. An I2 of 0%-25% represents insignificant heterogeneity, 26%-50% low heterogeneity, 51%-75% moderate heterogeneity and > 75% high heterogeneity[46]. To assess for publication bias funnel plots were used[47].

RESULTS

Our search strategy yielded 1554 articles. Of these, 1397 articles were excluded following the review of their title and abstract based on their relevance and the eligibility criteria. The remaining 157 articles underwent full-length review, and an additional 136 were excluded for failing to meet the criteria. Twenty one articles[12-29,36,38,40] met all inclusion criteria and were identified for the meta-analysis of kidney stones in kidney transplant recipients (Table 1). Supplementary Item 2 outlines our search methodology and selection process.

Table 1 Main characteristics of the studies included in this meta-analysis.
Ref.CountryYearTotal numberNo. of patients with kidney stoneTime of diagnosisSex of patients with stoneAge of patients with stoneDonorsStone locationStone compositionMean follow-up time
Cho et al[12]United States19885449Mean 14.7 mo, Median 7 mo (range 3-42 mo)6 male, 3 femaleMean 30 yr (range 8-65 yr)6 living, 3 cadaveric4 bladder, 3 kidney, 2 unknown4 calcium oxalate/calcium phosphate, 2 ammonium magnesium phosphate and carbonate appetite, 1 uric acid, 2 not studied5 (range 1.5-15.5) yr
Hayes et al[13]United States198989210Mean 13 mo (range 4-49 mo)7 male, 3 femaleMean 29 yr (range 17-53 yr)3 living, 7 cadavericNRNRNR
Harper et al[38]United Kingdom19941786NR4 male, 1 femaleNR4 living, 1 cadavericNR1 uric acid, 2 calcium phosphate, 1 calcium oxalate, 1 Magnesium ammonium phosphateNR
Shoskes et al[14]United Kingdom19958122Mean 3.5 yr (range 2-5 yr)NRMean 40 yrNR2 ureterNRAt least 1 yr
Benoit et al[36]France1996150012NR7 male, 5 femaleMean 36 yr2 living, 10 cadaveric5 calyces, 6 ureter, 1 pyeloureteral junction4 calcium oxalate and phosphate, 2 struviteNR
Del Pizzo et al[15]United States1998540 (445 renal transplant, 95 pancreas/renal transplant)4NRNRNRNRNRNR
Rhee et al[16]United States19991813 (1730 renal transplant, 83 pancreas/renal transplant)8NR4 male, 4 femaleMean 51 yr (range 34-60 yr)2 living, 1 cadaveric, 5 pancreas/renal3 kidney, 1 ureter, 4 bladder1 uric acid, 1 calcium oxalate, 1 calcium oxalate/calcium phosphate, 1 calcium phosphate, 1 struvite stone, 3 unknownMean 68.6 mo (range 27-98 mo)
El-Mekresh et al[17]Egypt2001120011NRNRNRNR3 kidney, 4 ureter, 4 bladderNRNR
Kim et al[18]United States200184915Mean 17.8 mo (range 3-109 mo)10 male, 5 femaleMean 41.5 yr (range 28-67 yr)8 living, 7 cadaveric11 bladder, 3 kidney, 1 multiple sites5 mixed form of calcium oxalate and calcium phosphate, 1 calcium oxalate, 3 predominant calcium phosphate, 2 struvite, 2 mixed form of struvite and calcium phosphate, 2 not studiedMean 58 mo (range 11-149 mo)
Klinger et al[19]Austria2002102719 (4 diagnosis during transplant, 5 perioperative, 10 de novo)For de novo: Mean 27.7 mo (range 13 to 48 mo)8 male, 11 femaleMean 48.1 yr (range 26-72 yr)1 living, 18 cadaveric14 kidney, 3 infundibulum, 1 distal ureter, 1 staghorn11 calcium oxalate, 2 uric acid, 1 calcium phosphate, 5 not studiedMean 29 mo (range 14-48 mo)
Doehn et al[20]Germany2002150011NR5 male, 6 femaleMedian 50 yr11 cadavericNR3 uric acid, 3 calcium oxalate, 2 magnesium ammonium stone, 3 not studiedMedian 4 yr
Streeter et al[21]United Kingdom2002153512For renal calculi: Median 150 d (range 56-1280 d); For bladder calculi: Range 8 mo - 4 yrNRNRNR9 ureter, 3 bladderNRNR
Abbott et al[22]United States20034290652NRNRNR35 kidney, 17 ureterNR1.89 ± 1.15 yr
Lipke et al[23]United States200450079 mo (range 1.5-26 mo)7 femaleMean 50 yr (range 8-73 yr)4 living, 3 cadaveric7 bladder7 mixed between calcium oxalate and calcium phosphateNR
Yigit et al[24]Turkey20041255 (2 preoperative, 1 early posttransplant, 2 de novo)For de novo: Mean 6.5 mo (range 6-7 mo)3 male, 2 femaleMean 35.2 yrNRNR2 calcium oxalate, 1 uric acid, 2 infectiousMean 32.4 mo
Challacombe et al[25]United Kingdom20052085213.7 (0.17-18) yr8 male, 13 femaleMean 41 yr (range 15-64 yr)3 living, 18 cadeveric13 kidney, 7 ureter, 1 bladderNRNR
Ferreira Cassini et al[26]Brazil2012131312 de novoRange 6 mo to 13 yr8 males, 9 femalesMean 45.6 yr (range 32-63 yr)2 living, 15 cadaveric6 calyces, 3 renal pelvis, 3 ureterNRNR
Stravodimos et al[27]Greece201215257Mean 3.2 (2-7) yrNRNRNR5 kidney, 2 ureterNRMean 8 yr
Cicerello et al[40]Italy201495310NR4 male, 6 femaleMean 43 yrNR7 kidney, 3 ureterNRNR
Mamarelis et al[28]Greece201420459Mean 3.1 yr (range 1-7 yr)NRNRNR6 kidney, 3 ureterNR6.6 yr (range 1-15 yr)
Rezaee-Zavereh et al[29]Iran201557425NRNRNRNRNRNR55 ± 53 mo
CaOx: Calcium oxalate; CaP: Calcium phosphate; NR: Not reported.
Incidence of kidney stones in kidney transplant recipients

The incidence of kidney stones after kidney transplantation within the 21 individual study ranged between 0.2% to 4.4% with an overall meta-analytical incidence of 1.0% (95%CI: 0.6%-1.4%)with evidence of a high level of heterogeneity (I2 = 93%, P < 0.001; Figure 1).

Figure 1
Open in New Tab   Full Size Figure   Download Figure
Figure 1 Forest plot of incidence of kidney stones in kidney transplant populations.

We performed a sensitivity analysis limited only to the studies that provided data on time of kidney stone diagnosis after kidney transplantation; the estimated incidence of kidney stones was 0.9% (95%CI: 0.7%-1.2%), and there was evidence of a high level of heterogeneity (I2 = 60%, P < 0.001; Figure 2). The mean duration to diagnosis of kidney stones after kidney transplantation was 28 ± 22 mo.

Figure 2
Open in New Tab   Full Size Figure   Download Figure
Figure 2 Forest plot of incidence of kidney stones in kidney transplant populations limited only to the studies that provided data on the time of kidney stone diagnosis after kidney transplantation.

Subgroup analyses by geographic information were also performed. The estimated incidences of kidney stones were 0.9% (95%CI: 0.3%-1.7%; I2 = 94%) and 0.7% (95%CI: 0.5%-0.9%; I2 = 40%) in the United States and Europe, respectively. Data on the incidence of kidney stones in kidney transplant recipients in other geographical area were limited as shown in Table 1.

Characteristics of kidney transplant recipients with kidney stones

The mean age of patients with kidney stones was 42 ± 7 years. Within reported studies (Table 1), approximately 50% of kidney transplant recipients with kidney stones were males.

Types of kidney stones in kidney transplant recipients

Sixty-seven percent of kidney stones were calcium-based stones (30% mixed CaOx/CaP, 27%CaOx and 10%CaP), followed by struvite stones (20%) and uric acid stones (13%) as shown in Table 1.

Risk factors for kidney stones in kidney transplant recipients

Despite limited data on urinary supersaturation and risk factors for kidney stones, studies reported increased risk of kidney stones in kidney transplant recipients with hyperparathyroidism, hypercalciuria, hypocitraturia, hypophosphatemia, and urinary tract infection[28,38]. Harper et al[38] found that urinary excretion of magnesium and phosphate was at the lower range for all kidney transplant recipients with kidney stones. Uncommonly, urinary outflow obstruction and foreign bodies were also found as risk factors for kidney stones in kidney transplant patients[28,48].

Allograft failure in kidney transplant recipients with kidney stones

As in general patient populations, kidney stones can also cause acute kidney injury in kidney transplant recipients[49-52]. Since kidney transplant recipients can have obstructed kidney stones without any symptom of pain[26,28], prompt diagnosis and the removal of obstructed stones are the keys to preventing renal allograft failure[18]. Rezaee-Zavareh et al[29] reported no significant association between kidney stones after transplantation and graft survival (OR = 1.04; CI: 0.71-1.54). With the prompt removal of stones, Kim et al[18] found no significant changes in renal allograft function at diagnosis and after removal of kidney stones.

Evaluation for publication bias

Funnel plot evaluating publication bias for the incidence of kidney stones in kidney transplant recipients demonstrated slight asymmetry of the graph and thus suggested the presence of publication for positive studies regarding the incidence of kidney stones.

DISCUSSION

In this study, we demonstrated that an overall incidence of kidney stones in kidney transplant recipients was 1.0%. The mean age of recipients with kidney stones was 42, and half of stone formers were males. Calcium based (CaOx and CaP) stones were the most common types of kidney stones after kidney transplantation, followed by struvite stones and then uric acid stones.

The incidence of kidney stones after kidney transplantation from our meta-analysis is much lower than reported in the general adult populations[5-8]. Although the mechanisms behind the lower incidence of kidney stones after kidney transplantation, when compared with the general population, are only speculative, there are several plausible explanations. First, with the observation that new kidney stones are usually formed in transplanted allograft kidney but not in native non-functioning kidneys, kidney transplant recipients have significantly improved but still lower GFRs than those in healthy general populations, which may be “protective” for stone disease[9,10]. Second, transplanted kidneys are from healthy donors ideally without tubulointerstitial defects, one not uncommon cause of kidney stones. Third, it is possible that kidney stones after kidney transplantation are underdiagnosed since recipients may spontaneously pass them from the transplanted kidney/ureter without pain or awareness.

Calcium based (CaOx and CaP) stones are the most common types of kidney stones in the general population as well as after kidney transplantation as demonstrated in our meta-analysis. Interestingly, struvite stones (ammonium magnesium phosphate) or “infection stones” is more common in kidney transplant recipients (20%) than in the general population (10%-15%)[53]. Since struvite stones are associated with infection with urea-splitting bacteria and the principles of treating struvite stones are different than other stones types, including removal of all stone fragments and use of antibiotics[53], this information is important for future studies targeting prevention and management of kidney stones after kidney transplantation.

There are several limitations to our study. First, there were statistical heterogeneities in the analysis of the incidence of kidney stones. The potential sources of this heterogeneity included differences in diagnostic methodology of kidney stones and follow-up duration. However, a sensitivity analysis that limited studies to those that only provided data on time of kidney stone diagnosis still showed a similar incidence rate of kidney stones, consistent with the finding of our primary analysis. Second, most included studies were conducted in developed Western countries with the majority of the subjects being Caucasian. Thus, our findings may not represent renal transplant populations from other parts of the world. Lastly, the data on urinary supersaturation and risk factors for kidney stones were limted. Although struvite stones represent an association with urinary tract infection, it is still unclear the risk factors for other stone types after kidney transplantation, and future studies are needed.

Our meta-analysis demonstrates that the estimated incidence of kidney stones in patients after kidney transplantation is 1.0%. Although calcium based stones are the most common kidney stones after transplantation, struvite stones are the second common type. These findings may impact clinical prevention and management of kidney stones in kidney transplant recipients.

COMMENTS
Background

Renal stones are one of the most prevalent metabolic disorders and urological problems. However, with reduced kidney functions, patients with advanced chronic kidney disease (CKD) or end-stage kidney disease (ESRD) may encounter less stone disease. After successful kidney transplantation, ESRD patients have significant improvement in kidney functions and may develop kidney stones in their allograft kidney.

Research frontiers

The incidence and characteristics of kidney stones in kidney transplant recipients are not well studied. It is thus necessary to assess the incidence and types of kidney stones after kidney transplantation.

Innovations and breakthroughs

In this study, the authors demonstrated that an overall incidence of kidney stones in kidney transplant recipients was 1.0%. The mean age of recipients with kidney stones was 42, and half of stone formers were males. Calcium based (CaOx and CaP) stones were the most common types of kidney stones after kidney transplantation, followed by struvite stones and then uric acid stones.

Applications

The data in this study demonstrates an estimated incidence of kidney stones in patients after kidney transplantation of 1.0%. Calcium based stones and struvite stones are common types of kidney stones after transplantation. These findings may impact the clinical management of kidney stones prevention in kidney transplant recipients.

Terminology

CaOx: Calcium oxalate; CaP: Calcium phosphate; CKD: Chronic kidney disease; GFR: Glomerular filtration rate; NR: Not reported.

Peer-review

This is a reasonable first meta-analysis of incidence of kidney stones in kidney transplant recipients. The results have potential clinical applications.

Footnotes

Manuscript source: Invited manuscript

Specialty type: Transplantation

Country of origin: United States

Peer-review report classification

Grade A (Excellent): A

Grade B (Very good): B

Grade C (Good): 0

Grade D (Fair): D

Grade E (Poor): 0

P- Reviewer: Friedman EA, Shrestha BM, Watanabe T S- Editor: Kong JX L- Editor: A E- Editor: Lu YJ

References
1.  Lieske JC, Peña de la Vega LS, Slezak JM, Bergstralh EJ, Leibson CL, Ho KL, Gettman MT. Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int. 2006;69:760-764.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 178]  [Cited by in F6Publishing: 167]  [Article Influence: 9.3]  [Reference Citation Analysis (0)]
2.  Sakhaee K. Nephrolithiasis as a systemic disorder. Curr Opin Nephrol Hypertens. 2008;17:304-309.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 105]  [Cited by in F6Publishing: 111]  [Article Influence: 6.9]  [Reference Citation Analysis (0)]
3.  Rule AD, Lieske JC, Li X, Melton LJ, Krambeck AE, Bergstralh EJ. The ROKS nomogram for predicting a second symptomatic stone episode. J Am Soc Nephrol. 2014;25:2878-2886.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 122]  [Cited by in F6Publishing: 150]  [Article Influence: 15.0]  [Reference Citation Analysis (0)]
4.  Cheungpasitporn W, Erickson SB, Rule AD, Enders F, Lieske JC. Short-Term Tolvaptan Increases Water Intake and Effectively Decreases Urinary Calcium Oxalate, Calcium Phosphate and Uric Acid Supersaturations. J Urol. 2016;195:1476-1481.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 14]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
5.  Goldfarb DS. Increasing prevalence of kidney stones in the United States. Kidney Int. 2003;63:1951-1952.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 57]  [Cited by in F6Publishing: 58]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
6.  Long LO, Park S. Update on nephrolithiasis management. Minerva Urol Nefrol. 2007;59:317-325.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  López M, Hoppe B. History, epidemiology and regional diversities of urolithiasis. Pediatr Nephrol. 2010;25:49-59.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 219]  [Cited by in F6Publishing: 233]  [Article Influence: 16.6]  [Reference Citation Analysis (0)]
8.  Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003;63:1817-1823.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 949]  [Cited by in F6Publishing: 929]  [Article Influence: 44.2]  [Reference Citation Analysis (0)]
9.  Marangella M, Bruno M, Cosseddu D, Manganaro M, Tricerri A, Vitale C, Linari F. Prevalence of chronic renal insufficiency in the course of idiopathic recurrent calcium stone disease: risk factors and patterns of progression. Nephron. 1990;54:302-306.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 41]  [Cited by in F6Publishing: 42]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
10.  Rule AD, Krambeck AE, Lieske JC. Chronic kidney disease in kidney stone formers. Clin J Am Soc Nephrol. 2011;6:2069-2075.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 116]  [Cited by in F6Publishing: 152]  [Article Influence: 11.7]  [Reference Citation Analysis (0)]
11.  Hippisley-Cox J, Coupland C. Predicting the risk of chronic Kidney Disease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores. BMC Fam Pract. 2010;11:49.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 116]  [Cited by in F6Publishing: 136]  [Article Influence: 9.7]  [Reference Citation Analysis (0)]
12.  Cho DK, Zackson DA, Cheigh J, Stubenbord WT, Stenzel KH. Urinary calculi in renal transplant recipients. Transplantation. 1988;45:899-902.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 37]  [Cited by in F6Publishing: 38]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
13.  Hayes JM, Streem SB, Graneto D, Hodge EE, Steinmuller DR, Novick AC. Renal transplant calculi. A reevaluation of risks and management. Transplantation. 1989;47:949-952.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 29]  [Cited by in F6Publishing: 31]  [Article Influence: 0.9]  [Reference Citation Analysis (0)]
14.  Shoskes DA, Hanbury D, Cranston D, Morris PJ. Urological complications in 1,000 consecutive renal transplant recipients. J Urol. 1995;153:18-21.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 250]  [Cited by in F6Publishing: 238]  [Article Influence: 8.2]  [Reference Citation Analysis (0)]
15.  Del Pizzo JJ, Jacobs SC, Sklar GN. Ureteroscopic evaluation in renal transplant recipients. J Endourol. 1998;12:135-138.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 40]  [Cited by in F6Publishing: 39]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
16.  Rhee BK, Bretan PN, Stoller ML. Urolithiasis in renal and combined pancreas/renal transplant recipients. J Urol. 1999;161:1458-1462.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 56]  [Cited by in F6Publishing: 42]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
17.  El-Mekresh M, Osman Y, Ali-El-Dein B, El-Diasty T, Ghoneim MA. Urological complications after living-donor renal transplantation. BJU Int. 2001;87:295-306.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 58]  [Cited by in F6Publishing: 57]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
18.  Kim H, Cheigh JS, Ham HW. Urinary stones following renal transplantation. Korean J Intern Med. 2001;16:118-122.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 37]  [Cited by in F6Publishing: 41]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
19.  Klingler HC, Kramer G, Lodde M, Marberger M. Urolithiasis in allograft kidneys. Urology. 2002;59:344-348.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 71]  [Cited by in F6Publishing: 66]  [Article Influence: 3.0]  [Reference Citation Analysis (0)]
20.  Doehn C, Fornara P, Tiemer C, Fricke L, Jocham D. Renal transplant lithiasis. Transplant Proc. 2002;34:2222-2223.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 10]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
21.  Streeter EH, Little DM, Cranston DW, Morris PJ. The urological complications of renal transplantation: a series of 1535 patients. BJU Int. 2002;90:627-634.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 175]  [Cited by in F6Publishing: 163]  [Article Influence: 7.4]  [Reference Citation Analysis (0)]
22.  Abbott KC, Schenkman N, Swanson SJ, Agodoa LY. Hospitalized nephrolithiasis after renal transplantation in the United States. Am J Transplant. 2003;3:465-470.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 46]  [Cited by in F6Publishing: 40]  [Article Influence: 1.9]  [Reference Citation Analysis (0)]
23.  Lipke M, Schulsinger D, Sheynkin Y, Frischer Z, Waltzer W. Endoscopic treatment of bladder calculi in post-renal transplant patients: a 10-year experience. J Endourol. 2004;18:787-790.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 14]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
24.  Yiğit B, Aydin C, Titiz I, Berber I, Sinanoğlu O, Altaca G. Stone disease in kidney transplantation. Transplant Proc. 2004;36:187-189.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 12]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
25.  Challacombe B, Dasgupta P, Tiptaft R, Glass J, Koffman G, Goldsmith D, Khan MS. Multimodal management of urolithiasis in renal transplantation. BJU Int. 2005;96:385-389.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 88]  [Cited by in F6Publishing: 75]  [Article Influence: 3.9]  [Reference Citation Analysis (0)]
26.  Ferreira Cassini M, Cologna AJ, Ferreira Andrade M, Lima GJ, Medeiros Albuquerque U, Pereira Martins AC, Tucci Junior S. Lithiasis in 1,313 kidney transplants: incidence, diagnosis, and management. Transplant Proc. 2012;44:2373-2375.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 24]  [Cited by in F6Publishing: 28]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
27.  Stravodimos KG, Adamis S, Tyritzis S, Georgios Z, Constantinides CA. Renal transplant lithiasis: analysis of our series and review of the literature. J Endourol. 2012;26:38-44.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 32]  [Cited by in F6Publishing: 39]  [Article Influence: 3.0]  [Reference Citation Analysis (0)]
28.  Mamarelis G, Vernadakis S, Moris D, Altanis N, Perdikouli M, Stravodimos K, Pappas P, Zavos G. Lithiasis of the renal allograft, a rare urological complication following renal transplantation: a single-center experience of 2,045 renal transplantations. Transplant Proc. 2014;46:3203-3205.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 16]  [Cited by in F6Publishing: 21]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
29.  Rezaee-Zavareh MS, Ajudani R, Ramezani Binabaj M, Heydari F, Einollahi B. Kidney Allograft Stone after Kidney Transplantation and its Association with Graft Survival. Int J Organ Transplant Med. 2015;6:114-118.  [PubMed]  [DOI]  [Cited in This Article: ]
30.  Rattiazzi LC, Simmons RL, Markland C, Casali R, Kjellstrand CM, Najarian JS. Calculi complicating renal transplantation into ileal conduits. Urology. 1975;5:29-31.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 20]  [Cited by in F6Publishing: 21]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
31.  Pena DR, Fennell RS, Iravani A, Neiberger RE, Richard GA. Renal calculi in pediatric renal transplant recipients. Child Nephrol Urol. 1990;10:58-60.  [PubMed]  [DOI]  [Cited in This Article: ]
32.  Lancina Martín JA, García Buitrón JM, Díaz Bermúdez J, Alvarez Castelo L, Duarte Novo J, Sánchez Merino JM, Rubial Moldes M, González Martín M. [Urinary lithiasis in transplanted kidney]. Arch Esp Urol. 1997;50:141-150.  [PubMed]  [DOI]  [Cited in This Article: ]
33.  Narayana AS, Loening S, Culp DA. Kidney stones and renal transplantation. Urology. 1978;12:61-63.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in F6Publishing: 10]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
34.  Rosenberg JC, Arnstein AR, Ing TS, Pierce JM, Rosenberg B, Silva Y, Walt AJ. Calculi complicating a renal transplant. Am J Surg. 1975;129:326-330.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 31]  [Cited by in F6Publishing: 32]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
35.  Solà R, del Río G, Villavicencio H. Staghorn renal stone in a transplanted kidney. Urol Int. 1990;45:188-189.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3]  [Cited by in F6Publishing: 3]  [Article Influence: 0.1]  [Reference Citation Analysis (0)]
36.  Benoit G, Blanchet P, Eschwege P, Jardin A, Charpentier B. Occurrence and treatment of kidney graft lithiasis in a series of 1500 patients. Clin Transplant. 1996;10:176-180.  [PubMed]  [DOI]  [Cited in This Article: ]
37.  Crook TJ, Keoghane SR. Renal transplant lithiasis: rare but time-consuming. BJU Int. 2005;95:931-933.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 34]  [Cited by in F6Publishing: 28]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
38.  Harper JM, Samuell CT, Hallson PC, Wood SM, Mansell MA. Risk factors for calculus formation in patients with renal transplants. Br J Urol. 1994;74:147-150.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 65]  [Cited by in F6Publishing: 55]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
39.  Khositseth S, Gillingham KJ, Cook ME, Chavers BM. Urolithiasis after kidney transplantation in pediatric recipients: a single center report. Transplantation. 2004;78:1319-1323.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 25]  [Cited by in F6Publishing: 27]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
40.  Cicerello E, Merlo F, Mangano M, Cova G, Maccatrozzo L. Urolithiasis in renal transplantation: diagnosis and management. Arch Ital Urol Androl. 2014;86:257-260.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 12]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
41.  Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 16777]  [Cited by in F6Publishing: 16791]  [Article Influence: 1119.4]  [Reference Citation Analysis (1)]
42.  Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14425]  [Cited by in F6Publishing: 16113]  [Article Influence: 671.4]  [Reference Citation Analysis (0)]
43.  STROBE statement--checklist of items that should be included in reports of observational studies (STROBE initiative). Int J Public Health. 2008;53:3-4.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 59]  [Cited by in F6Publishing: 123]  [Article Influence: 7.7]  [Reference Citation Analysis (0)]
44.  Barendregt JJ, Doi SA. MetaXL User Guide: Version 1.0. Wilston, Australia: EpiGear International Pty Ltd 2010; .  [PubMed]  [DOI]  [Cited in This Article: ]
45.  DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials. 2007;28:105-114.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1378]  [Cited by in F6Publishing: 1678]  [Article Influence: 93.2]  [Reference Citation Analysis (0)]
46.  Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 39087]  [Cited by in F6Publishing: 43703]  [Article Influence: 2081.1]  [Reference Citation Analysis (1)]
47.  Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet. 1991;337:867-872.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2020]  [Cited by in F6Publishing: 1967]  [Article Influence: 59.6]  [Reference Citation Analysis (0)]
48.  Verrier C, Bessede T, Hajj P, Aoubid L, Eschwege P, Benoit G. Decrease in and management of urolithiasis after kidney transplantation. J Urol. 2012;187:1651-1655.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 29]  [Cited by in F6Publishing: 36]  [Article Influence: 3.0]  [Reference Citation Analysis (0)]
49.  Lusenti T, Fiorini F, Barozzi L. Obstructive uropathy and acute renal failure due to ureteral calculus in renal graft: a case report. J Ultrasound. 2009;12:128-132.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 4]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
50.  Gómez García I, Burgos Revilla FJ, Sanz Mayayo E, Rodríguez Patrón R, Arias Fúnez F, Marcen R, Pascual J, Escudero Barrilero A. [Acute obstructive kidney failure after kidney transplantation caused by calculi transfer from donor]. Arch Esp Urol. 2003;56:1047-1050.  [PubMed]  [DOI]  [Cited in This Article: ]
51.  Qazi YA, Ali Y, Venuto RC. Donor calculi induced acute renal failure. Ren Fail. 2003;25:315-322.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5]  [Cited by in F6Publishing: 5]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
52.  Fabbian F, Catalano C, Rizzioli E, Normanno M, Conz PA. Acute renal failure due to a calculus obstructing a transplanted kidney. Nephron. 2002;91:742-743.  [PubMed]  [DOI]  [Cited in This Article: ]
53.  Flannigan R, Choy WH, Chew B, Lange D. Renal struvite stones--pathogenesis, microbiology, and management strategies. Nat Rev Urol. 2014;11:333-341.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 121]  [Cited by in F6Publishing: 137]  [Article Influence: 13.7]  [Reference Citation Analysis (0)]